Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein

[1]  C. Elston,et al.  Methodology of immunohistological detection of oestrogen receptor in human breast carcinoma in formalin‐fixed, paraffin‐embedded tissue: a comparison with frozen section methodology , 1993, Histopathology.

[2]  J. Cowl,et al.  Oestrogen receptor, epidermal growth factor receptor and oncoprotein expression in non-involved tissue of cancerous breasts , 1992 .

[3]  R. Blamey,et al.  Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer. , 1992, British Journal of Cancer.

[4]  O. Haugen,et al.  Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods. , 1992, Journal of clinical pathology.

[5]  I. Ellis,et al.  Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation. , 1991, European journal of cancer.

[6]  L. Jin,et al.  Detection of Estrogen Receptor in Paraffin‐Embedded Sections of Breast Carcinoma by Immunohistochemistry and In Situ Hybridization , 1991, The American journal of surgical pathology.

[7]  I. Ellis,et al.  c-erbB-2 oncoprotein expression in primary and advanced breast cancer. , 1991, British Journal of Cancer.

[8]  S. Masood,et al.  Potential value of hormone receptor assay in carcinoma in situ of breast. , 1990, American journal of clinical pathology.

[9]  N. Thomford,et al.  Estrogen receptors in ductal carcinoma in situ of breast. , 1990, The American surgeon.

[10]  M. Pfahl,et al.  The human estrogen receptor has transcriptional activator and repressor functions in the absence of ligand. , 1990, The New biologist.

[11]  I. Fentiman.  Treatment of screen detected ductal carcinoma in situ: a silver lining within a grey cloud? , 1990, British Journal of Cancer.

[12]  I. Ellis,et al.  Flow cytometric and histological analysis of ductal carcinoma in situ of the breast , 1990, The British journal of surgery.

[13]  A. Leong,et al.  Oestrogen receptor staining of paraffin‐embedded breast carcinomas following short fixation in formalin: A comparison with cytosolic and frozen section receptor analyses , 1990, The Journal of pathology.

[14]  J. Elias,et al.  Estrogen Receptor Localization in Paraffin Sections By Enzyme Digestion, Repeated Applications of Primary Antibody, and Imidazole , 1990 .

[15]  T. Anderson,et al.  Assessment of oestrogen receptor content of breast carcinoma by immunohistochemical techniques on fixed and frozen tissue and by biochemical ligand binding assay. , 1990, Journal of clinical pathology.

[16]  D. Giri,et al.  Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study , 1989, Histopathology.

[17]  I. Ellis,et al.  Immunocytochemical localization of estrogen receptor in human breast tissue. , 1988, Cancer research.

[18]  M. J. van de Vijver,et al.  Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. , 1988, The New England journal of medicine.

[19]  K. Lewin,et al.  Demonstration of estrogen receptors by monoclonal antibody in formalin-fixed breast tumors. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[20]  I. O. Ellis,et al.  Confirmation of a prognostic index in primary breast cancer. , 1987, British Journal of Cancer.

[21]  W. Gullick,et al.  OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATION , 1987, The Lancet.

[22]  J. Said,et al.  Detection of estrogen receptors with monoclonal antibodies in routinely processed formalin-fixed paraffin sections of breast carcinoma. Use of DNase pretreatment to enhance sensitivity of the reaction. , 1987, American journal of clinical pathology.

[23]  J. Jacquemier,et al.  Estrogen receptor immunocytochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas. , 1986, Cancer research.

[24]  E B Cox,et al.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. , 1985, Archives of pathology & laboratory medicine.

[25]  I. Taylor,et al.  Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. , 1985, Cytometry.

[26]  A. C. Carter,et al.  Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies. Correlation with biochemistry and clinical endocrine response , 1985, Cancer.

[27]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[28]  Jerry R. Hobbs,et al.  HORMONE SENSITIVITY IN BREAST CANCER , 1975, The Lancet.

[29]  W. Göhde,et al.  Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle , 1975, Radiation and environmental biophysics.

[30]  D. Wilbur,et al.  Estrogen and progesterone receptor detection in archival formalin-fixed, paraffin-embedded tissue from breast carcinoma: a comparison of immunohistochemistry with the dextran-coated charcoal assay. , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.